Literature DB >> 11900961

Peroxisome proliferator-activated receptor gamma (PPARgamma) and its ligands: a review.

Karen L Houseknecht1, Bridget M Cole, Pamela J Steele.   

Abstract

Peroxisome proliferator-activated receptor gamma (PPARgamma) is a member of a class of nuclear hormone receptors intimately involved in the regulation of expression of myriad genes that regulate energy metabolism, cell differentiation, apoptosis and inflammation. Although originally discovered as a pivotal regulator of adipocyte differentiation, the roles that this transcription factor play in physiology and pathophysiology continue to grow as researchers discover its influence in the function of many cell types. This review highlights the roles that PPARgamma play in the regulation of gene expression associated with normal cell physiology as well as the pathophysiology of multiple diseases including obesity, diabetes and cancer. Additionally, naturally occurring and pharmaceutical ligands for the receptor as well as the potential role of PPARgamma as the receptor responsible for fatty acid-induced effects on gene expression will be described.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11900961     DOI: 10.1016/s0739-7240(01)00117-5

Source DB:  PubMed          Journal:  Domest Anim Endocrinol        ISSN: 0739-7240            Impact factor:   2.290


  52 in total

Review 1.  Role of NYGGF4 in insulin resistance.

Authors:  Xiaoling Chen; Zhiqing Huang; Daiwen Chen; Gang Jia; Xiangbing Mao; Xiuqun Wu
Journal:  Mol Biol Rep       Date:  2011-12-13       Impact factor: 2.316

Review 2.  Significance of anti-inflammatory effects of PPARgamma agonists?

Authors:  G Rogler
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

3.  Supplementing calcium salts of soybean oil to beef steers early in life to enhance carcass development and quality1.

Authors:  Kelsey M Schubach; Reinaldo F Cooke; Alice P Brandão; Osvaldo A de Sousa; Thiago F Schumaher; Donald B Jump; Ky G Pohler; David W Bohnert; Rodrigo S Marques
Journal:  J Anim Sci       Date:  2019-10-03       Impact factor: 3.159

4.  Activation of PPARgamma is required for curcumin to induce apoptosis and to inhibit the expression of extracellular matrix genes in hepatic stellate cells in vitro.

Authors:  Shizhong Zheng; Anping Chen
Journal:  Biochem J       Date:  2004-11-15       Impact factor: 3.857

5.  Effect of chronic treatment with Rosiglitazone on Leydig cell steroidogenesis in rats: in vivo and ex vivo studies.

Authors:  Janaína A Couto; Karina L A Saraiva; Cleiton D Barros; Daniel P Udrisar; Christina A Peixoto; Juliany S B César Vieira; Maria C Lima; Suely L Galdino; Ivan R Pitta; Maria I Wanderley
Journal:  Reprod Biol Endocrinol       Date:  2010-02-09       Impact factor: 5.211

6.  Anticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes.

Authors:  P J Simpson-Haidaris; S J Pollock; S Ramon; N Guo; C F Woeller; S E Feldon; R P Phipps
Journal:  PPAR Res       Date:  2010-02-28       Impact factor: 4.964

7.  The Role of PPARα Activation in Liver and Muscle.

Authors:  Lena Burri; G Hege Thoresen; Rolf K Berge
Journal:  PPAR Res       Date:  2010-08-18       Impact factor: 4.964

8.  Effects of chronic PPAR-agonist treatment on cardiac structure and function, blood pressure, and kidney in healthy sprague-dawley rats.

Authors:  Eileen R Blasi; Jonathan Heyen; Michelle Hemkens; Aileen McHarg; Carolyn M Ecelbarger; Swasti Tiwari
Journal:  PPAR Res       Date:  2009-06-11       Impact factor: 4.964

9.  Curcumin decreased oxidative stress, inhibited NF-kappaB activation, and improved liver pathology in ethanol-induced liver injury in rats.

Authors:  Suchittra Samuhasaneeto; Duangporn Thong-Ngam; Onanong Kulaputana; Doungsamon Suyasunanont; Naruemon Klaikeaw
Journal:  J Biomed Biotechnol       Date:  2009-07-06

10.  Down-regulation of PPARgamma1 suppresses cell growth and induces apoptosis in MCF-7 breast cancer cells.

Authors:  Yekaterina Y Zaytseva; Xin Wang; R Chase Southard; Natalie K Wallis; Michael W Kilgore
Journal:  Mol Cancer       Date:  2008-12-05       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.